Akso Health Group Valuation

Q: What is the Fair Price of AHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

AHG ($0.88) is trading below our estimate of [[fair value]] ($1.43)

Is AHG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AHG ($0.88) is trading below our estimate of fair value ($1.43)

Significantly Below Fair Value: AHG is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AHG?

Key metric: As AHG barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for AHG. This is calculated by dividing AHG's market cap by their current book value.
What is AHG's PB Ratio?
PB Ratio	1.1x
Book	US$138.37m
Market Cap	US$146.59m

AHG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	26.3x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does AHG's PB Ratio compare to its peers?

The above table shows the PB ratio for AHG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	91.1x
NOTR Nowtransit	362.2x	n/a	US$41.6m
OMI Owens & Minor	1.1x	95.0%	US$952.3m
AHCO AdaptHealth	0.9x	89.2%	US$1.3b
COSM Cosmos Health	0.4x	n/a	US$15.6m
AHG Akso Health Group	1.1x	n/a	US$146.6m

Price-To-Book vs Peers: AHG is good value based on its Price-To-Book Ratio (1.1x) compared to the peer average (91.1x).

Price to Book Ratio vs Industry

How does AHG's PB Ratio compare vs other companies in the US Healthcare Industry?

8 Companies	Price / Book	Estimated Growth	Market Cap
PIII P3 Health Partners	0.3x	35.8%	US$76.43m
PRE Prenetics Global	0.3x	76.9%	US$54.00m
ALR AlerisLife	0.3x	63.8%	US$44.14m
LIFW MSP Recovery	0.01x	n/a	US$13.18m

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: AHG is good value based on its Price-To-Book Ratio (1.1x) compared to the US Healthcare industry average (2.1x).

Price to Book Ratio vs Fair Ratio

What is AHG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AHG PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	1.1x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate AHG's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elevance Health

US$93.6b

Operates as a health benefits company in the United States.

ELV

US$402.55

0.5%

-15.9%

Centene

US$30.5b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$60.37

5.1%

-18.8%

electroCore

US$64.0m

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.

ECOR

US$11.21

2.5%

101.6%